Filing Details
- Accession Number:
- 0001209191-21-060463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-10-14 16:24:44
- Reporting Period:
- 2021-10-12
- Accepted Time:
- 2021-10-14 16:24:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1615055 | Isoplexis Corp | ISO | Laboratory Analytical Instruments (3826) | 462179799 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1867470 | Northpond Ventures Gp, Llc | 7500 Old Georgetown Road Suite 850 Bethesda MD 20814 | No | No | Yes | No | |
1867472 | Northpond Ventures, Lp | 7500 Old Georgetown Road Suite 850 Bethesda MD 20814 | No | No | Yes | No | |
1867627 | P. Michael Rubin | C/O Northpond Ventures 7500 Old Georgetown Road, Suite 850 Bethesda MD 20814 | No | No | Yes | No | |
1871659 | Northpond Capital, L.p. | 7500 Old Georgetown Road Suite 850 Bethesda MD 20814 | No | No | Yes | No | |
1871669 | Northpond Capital Gp, Llc | 7500 Old Georgetown Road Suite 850 Bethesda MD 20814 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-10-12 | 6,304,192 | $0.00 | 6,727,570 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2021-10-12 | 1,040,048 | $0.00 | 1,080,961 | No | 4 | C | Indirect | See footnote |
Common Stock | Acquisiton | 2021-10-12 | 1,000,000 | $15.00 | 2,080,961 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnote |
No | 4 | C | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Redeemable Convertible Preferred Stock | Disposition | 2021-10-12 | 287,785 | $0.00 | 2,302,280 | $0.00 |
Common Stock | Series C-2 Redeemable Convertible Preferred Stock | Disposition | 2021-10-12 | 309,131 | $0.00 | 2,473,048 | $0.00 |
Common Stock | Series D Redeemable Convertible Preferred Stock | Disposition | 2021-10-12 | 191,108 | $0.00 | 1,528,864 | $0.00 |
Common Stock | Series D Redeemable Convertible Preferred Stock | Disposition | 2021-10-12 | 130,006 | $0.00 | 1,040,048 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of the Series C Redeemable Convertible Preferred Stock, Series C-2 Redeemable Convertible Preferred Stock and Series D Redeemable Convertible Preferred Stock automatically converted on a one-for-8 basis into Common Stock upon the consummation of the Issuer's initial public offering. The preferred stock had no expiration date.
- Includes 423,378 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.
- The securities are held directly by Northpond Ventures, LP ("Northpond"). Northpond Ventures GP, LLC ("Northpond GP") is the general partnerof Northpond. Michael P. Rubin ("Rubin") is the managing member of Northpond GP.
- Includes 40,913 shares of Common Stock issued per dividends accrued to but not including October 12, 2021.
- The securities are held directly by Northpond Capital, LP ("Northpond Capital"). Northpond Capital GP, LLC ("Northpond Capital GP") is the general partner of Northpond Capital. Rubin is the managing member of Northpond Capital GP.